The following article was featured in:
Source:
PhillyVoice
11/26/2024.
About 7 million people enrolled in Medicare and Medicaid would gain access to weight-loss drugs like Ozempic, Wegovy, Zepbound and Mounjaro, which are not covered by these federal programs, under a...
Continue on to full article...
